期刊文献+

曲古抑菌素A诱导Hela细胞凋亡过程中端粒酶逆转录酶表达的变化 被引量:1

The Change in Expression of Human Telomerase Reverse Transcriptase during Induction of Apoptosis by Trichostatin A in Hela Human Cervical Cancer Cells
下载PDF
导出
摘要 目的:观察Trichostatin A(TSA)对子宫颈癌细胞株Hela细胞的体外作用,探讨TSA对子宫颈癌细胞的作用机制,以及细胞凋亡与端粒酶逆转录酶(human telomerase reverse transcriptase,hTERT)之间的关系。方法:倒置相差显微镜观察细胞形态变化;磺酰罗丹明B(sulforhodamine B;SRB)法检测药物动力学特征;流式细胞仪检测药物作用前后Hela细胞凋亡情况;RT-PCR检测hTERT和p21Waf1基因变化;免疫荧光检测TSA作用前后hTERT表达变化。结果:在0.5~2.0μmol/LTSA作用下,Hela细胞生长明显受抑制。倒置相差显微镜检测Hela细胞经TSA处理后形态发生明显变化。2.0μmol/LTSA作用于Hela细胞,48h以前表现细胞周期的变化,48h后则出现明显的凋亡。hTERT经1.0μmol/LTSA诱导后表达下调,呈时效关系。免疫荧光检测hTERT蛋白经1μmol/LTSA处理后表达下降;结论:一定浓度的TSA可以诱导子宫颈癌细胞株Hela凋亡,其作用机制可能与下调hTERT表达有关。 Objective: To investigate the in vitro effect of Trichostatin A (TSA) on Hela human cervical cancer cells in order to reveal its probable mechanism and to elucidate the relationship between apoptosis and the expression of human telomerase reverse transcriptase (hTERT). Methods: Inverted phase contrast microscopy (IPCM) was used to observe morphologic changes in the cells. Sulforhodamine B was employed to determine the pharmacokinetic characteristics. Flow cytometry(FCM) was conducted to measure apoptosis before and after drug treatment. The expression levels of hTERT and p21/Wafl mRNA, before and after Trichostatin A treatment, were detected using semi-quantitative reverse transcription po!ymerase chain reaction (RT-PCR). The hTERT protein expression level before and after TSA treatment was detected by fluorescence microscopy. Results: After being treated with 0.1uM, 0.5uM, 1.0uM, and 2.0uM Trichostatin A, the proliferation of Hela cells was significantly inhibited. IPCM showed that there were obvious morphologic changes after TSA treatment. Changes in the cell cycle occurred 48 h after treatment, and with a dose of 2.0umol/L TSA apoptosis was apparent.hTERT expression was down-regulated after treatment with 1.0umol/L TSA, in a time-dependent man- ner. Immunofluorescence detection showed that there was decreased expression of the hTERT protein after the 1 umol/L TSA treatment. Conclusion: Trichostatin A significantly inhibited growth of Hela cells by inducing apoptosis and the mechanism may be related to a down-regulation in hTERT expression.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2007年第8期421-425,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金(编号:30371657 30500596) 国家重大基础研究基金资助(编号:2002CB513107)
关键词 曲古抑菌素A 宫颈癌 凋亡 端粒酶逆转录酶 Trichostatin A Cervical cancer Apoptosis Human telomerase reverse transcriptase (hTERT)
  • 相关文献

参考文献11

  • 1Pandolfi PP.Transcription therapy for cancer[J].Oncogene,2001,20(24):3116~3127
  • 2刘红利,陈燕,李新刚,吴青,谷俊侠.hGCN5在Burkkit淋巴瘤细胞株Daudi中的表达及TSA对细胞增殖凋亡的影响[J].中国肿瘤临床,2005,32(16):901-905. 被引量:1
  • 3Suenaga M,Soda H,Oka M,et al.Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells[J].IntJ Cancer,2002,97(5):621~625
  • 4Wang Z,Kyo S,Takakura M,et al.Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway[J].Cancer Res,2000,60(19):5376~5381
  • 5Henderson YC,Breau RL,Liu TJ,et al.Telomerase activity in head and neck tumors after introduction of wild-type p53,p21,p16,and E2F-1 genes by means of recombinant adenovirus[J].Head Neck,2000,22(4):347~354
  • 6TsurutaniJ,Soda H,Oka M,et al.Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines[J].IntJ Cancer,2003,104(2):238~242
  • 7Richon VM,Sandhoff TW,Rifkind RA,et al.Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation[J].Proc Natl Acad Sci U S A,2000,97(18):10014~10019
  • 8吴继锋,邵晋晨,王道斌,秦蓉,张红.胃癌组织端粒酶逆转录酶基因的表达及意义[J].中国肿瘤临床,2004,31(5):289-291. 被引量:6
  • 9Kyo S,Kanaya T,Takakura M,et al.Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues[J].IntJ Cancer,1999,80(1):60~63
  • 10Hou M,Wang X,Popov N,et al.The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells[J].Exp Cell Res,2002,274(1):25~34

二级参考文献12

  • 1Yang WM, Tsai SC, Wen YD, et al. Functional domains of histone deacetylase-3[J]. Biol Chem, 2002, 77(11): 9447~9454.
  • 2Kahata K, Hayashi M, Asaka M, et al. Regulation of transforming growth factor--beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5 [J]. Genes Cells, 2004, 9 (2):143~151.
  • 3Furumai R, Matsuyama A, Kobashi N, et al. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases [J]. Cancer Res, 2002, 62(17): 4916~4921.
  • 4Yamashita Y, Shimada M, Harimoto N, et al. Histone deacetylase inhibitor trichostatin A induces cellcycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells [J]. Int J Cancer,2003, 103(5): 572~576.
  • 5Mariadason JM, Comer GA, Augenlicht LH. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer [J]. Cancer Res, 2000,60(16): 4561~4572.
  • 6Murata M, Towatari M, Kosugi H, et al. Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, onmalignant lymphoid cells[J].JpnJ Cancer Res, 2000, 91(11): 1154~1160.
  • 7Owa T, Yoshino H, Yoshimatsu K, et al. Cell cyde regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents [J]. Curr Med Chem, 2001, 8(12): 1487~1503.
  • 8Alao JP, Lam EW, Ali S, et al. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines [J]. Clin Cancer Res, 2004, 10(23): 8094 ~ 8104.
  • 9Hu ED, Chen ZX, Fredrickson T, et al. Cloing and Chracterization of a Novel Human Class I Histone deacetylase That Functions as a Transcription Repressor [J]. Bio Chem, 2000, 275(20):15254 ~ 15264.
  • 10Secrist JP, Zhou X, Richon VM. HDAC inhibitors for the treatment of cancer[J]. Curr Opin Investig Drugs, 2003, 4(12): 1422~1427.

共引文献5

同被引文献14

  • 1JingYuanFANG YingXuanCHEN JuanLU RongLU LiYANG HongYinZHU WeiQiGU LunGenLU.Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116[J].Cell Research,2004,14(3):217-226. 被引量:46
  • 2Are C,Shaha AR. Anaplastie thyroid carcinonla:biology. pathogenesis, prognostic factors, and treatment approaches [J]. Ann Surg Oncol,2006,13(4):453-464.
  • 3Voigt W, Kegel T, Weiss M, et al. Potential activity of paclitaxel,viuorelbine and gertrcitabine in anaplastie thyroid cacinoima [J]. J Cancer Res Clin Oncol,2005,131 (9) :585-590.
  • 4Curtin M, Glaser K. Histon deacetylase inhibitor: the Abbott experience [J]. Curr Med Chem,2003,10 (22): 2373-2392.
  • 5Pandolfi PP. Transcription therapy for cancer [J]. Onco-gene, 2001,20(24) : 3116-3127.
  • 6Park WH,Jung CW, Park JO,et al. Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27,or apoptosis[J]. Int J Oncol, 2003,22:1129-1134.
  • 7Rust C,Gores GJ. Apoptosis and liver disease [J]. Am J Med, 2000, 108 : 567-574.
  • 8Shami PJ, Sauls DL, Weinberg JB. Schedule and concen- tration-dependent induction of apoptos is in leukemia ceils by nitric oxide [ J ]. Leukemia, 1998,12 : 1461-1466.
  • 9Kyo S, Kanaya T,Takakura M,et al. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues[J]. Int J Cancer, 1999,80( 1 ):60-63.
  • 10Suenaga M,Soda H,Oka M,et al. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in protease cancer cells [J]. Int J Cancer, 2002,97(5) :621-625.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部